Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria

被引:25
作者
Mazurier, F
MoreauGaudry, F
Salesse, S
Barbot, C
Ged, C
Reiffers, J
DeVerneuil, H
机构
[1] UNIV BORDEAUX 2,LAB PATHOL MOL & THERAPIE GEN,F-33076 BORDEAUX,FRANCE
[2] UNIV BORDEAUX 2,LAB GREFFE MOELLE,F-33076 BORDEAUX,FRANCE
关键词
D O I
10.1023/A:1005365008147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congenital erythropoietic porphyria (CEP) is an inherited metabolic disorder characterized by an overproduction and accumulation of porphyrins in bone marrow. This autosomal recessive disease results from a deficiency of uroporphyrinogen III synthase (UROIIIS), the fourth enzyme of the haem biosynthetic pathway. It is phenotypically heterogeneous: patients with mild disease have cutaneous involvement, while more severely affected patients are transfusion dependent. The cloning of UROIIIS cDNA and genomic DNA has allowed the molecular characterization of the genetic defect in a number of families. To date, 22 different mutations have been characterized. Allogeneic bone marrow transplantation is the only curative treatment available for the severe, transfusion-dependent, cases. When bone marrow transplantation cannot be performed owing to the absence of a suitable donor, the autografting of genetically modified cells is an appealing alternative. The best approach to somatic gene therapy in this disease involves the use of recombinant retroviral vectors to transduce cells ex vivo, followed by autologous transplantation of the genetically modified cells. We investigated retroviral transfer in deficient human fibroblasts, immortalized lymphoblasts as well as bone marrow cells, and obtained a complete restoration of the enzymatic activity and full metabolic correction. Using K562 cells, an erythroleukaemic cell line, the expression of the transgene remained stable during 3 months and during erythroid differentiation of the cells. Finally, a 1.6- to 1.9-fold increase in enzyme activity compared to the endogenous level was found in normal CD34(+) cells, a population of heterogeneous cells known to contain the progenitor/stem cells for long-term expression. The future availability of a mouse model of the disease will permit ex vivo gene therapy experiments on the entire animal.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 35 条
[1]  
BENSIDHOUM M, 1995, EUR J HUM GENET, V3, P102
[2]   T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS [J].
BLAESE, RM ;
CULVER, KW ;
MILLER, AD ;
CARTER, CS ;
FLEISHER, T ;
CLERICI, M ;
SHEARER, G ;
CHANG, L ;
CHIANG, YW ;
TOLSTOSHEV, P ;
GREENBLATT, JJ ;
ROSENBERG, SA ;
KLEIN, H ;
BERGER, M ;
MULLEN, CA ;
RAMSEY, WJ ;
MUUL, L ;
MORGAN, RA ;
ANDERSON, WF .
SCIENCE, 1995, 270 (5235) :475-480
[3]   GENE-THERAPY IN PERIPHERAL-BLOOD LYMPHOCYTES AND BONE-MARROW FOR ADA(-) IMMUNODEFICIENT PATIENTS [J].
BORDIGNON, C ;
NOTARANGELO, LD ;
NOBILI, N ;
FERRARI, G ;
CASORATI, G ;
PANINA, P ;
MAZZOLARI, E ;
MAGGIONI, D ;
ROSSI, C ;
SERVIDA, P ;
UGAZIO, AG ;
MAVILIO, F .
SCIENCE, 1995, 270 (5235) :470-475
[4]   HETEROGENEITY OF MUTATIONS IN THE UROPORPHYRINOGEN-III SYNTHASE GENE IN CONGENITAL ERYTHROPOIETIC PORPHYRIA [J].
BOULECHFAR, S ;
DASILVA, V ;
DEYBACH, JC ;
NORDMANN, Y ;
GRANDCHAMP, B ;
DEVERNEUIL, H .
HUMAN GENETICS, 1992, 88 (03) :320-324
[5]   PORPHYRIAS - ANIMAL-MODELS AND PROSPECTS FOR CELLULAR AND GENE-THERAPY [J].
DEVERNEUIL, H ;
GED, C ;
BOULECHFAR, S ;
MOREAUGAUDRY, F .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1995, 27 (02) :239-248
[6]   FATAL CASE OF CONGENITAL ERYTHROPOIETIC PORPHYRIA IN A NEONATE WITH ACUTE HEMOLYSIS AND HEPATIC-FAILURE [J].
DEVERNEUIL, H ;
MOREAUGAUDRY, F ;
GED, C ;
BENSIDHOUM, M ;
HOMBRADOS, I ;
TRICOIRE, J ;
ROLLAND, M .
ARCHIVES DE PEDIATRIE, 1995, 2 (08) :755-761
[7]  
DEYBACH JC, 1981, J LAB CLIN MED, V97, P551
[8]  
DEYBACH JC, 1990, BLOOD, V75, P1763
[9]   GENE-TRANSFER INTO HEMATOPOIETIC PROGENITOR AND STEM-CELLS - PROGRESS AND PROBLEMS [J].
DUNBAR, CE ;
EMMONS, RVB .
STEM CELLS, 1994, 12 (06) :563-576
[10]  
EAVES C, 1995, COLLOQ INSE, V234, P589